Cronos (CRON) Income from Non-Controlling Interests (2019 - 2026)

Cronos' (CRON) quarterly Income from Non-Controlling Interests came in at $1.1 million in Q1 2026, down 31.92% year-on-year from $1.6 million in Q1 2025, and up 3105.88% quarter-over-quarter from $34000.0 in Q4 2025.

Cronos (CRON) Income from Non-Controlling Interests (2019 - 2026) Analysis & Trends

Cronos' Income from Non-Controlling Interests history runs 8 years deep, the most recent figure standing at $1.1 million for Q1 2026.

  • On a quarterly basis, Income from Non-Controlling Interests fell 31.92% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $4.7 million, a 665.58% increase from a year earlier, with the FY2025 full-year figure at $6.5 million, up 716.07% from the prior year.
  • Income from Non-Controlling Interests advanced to $1.1 million in Q1 2026 per CRON's latest filing, from $34000.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $2.4 million in Q3 2025 and bottomed at -$714000.0 in Q4 2024.
  • The 5-year median for Income from Non-Controlling Interests is -$8000.0 (2023), against an average of $298117.6.
  • Across the five-year window, Income from Non-Controlling Interests sank 1562.5% in 2024 and surged 61550.0% in 2025, its largest moves.
  • Year by year, Income from Non-Controlling Interests stood at -$16000.0 in 2022, then tumbled by 1381.25% to -$237000.0 in 2023, then sank by 201.27% to -$714000.0 in 2024, then soared by 104.76% to $34000.0 in 2025, then soared by 3105.88% to $1.1 million in 2026.
  • Per Business Quant, the three latest CRON Income from Non-Controlling Interests figures stand at $1.1 million (Q1 2026), $34000.0 (Q4 2025), and $2.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 395,346.10
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -12.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Cronos 1.04 Bn 267.78 Mn 19.15 Mn 1.09 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.09 Mn
Dec 31, 2025 34,000.00
Sep 30, 2025 2.36 Mn
Jun 30, 2025 1.23 Mn
Mar 31, 2025 1.60 Mn
Dec 31, 2024 -714,000.00
Sep 30, 2024 -269,000.00
Jun 30, 2024 -2,000.00
Mar 31, 2024 -133,000.00
Dec 31, 2023 -237,000.00
Sep 30, 2023 -41,000.00
Jun 30, 2023 -137,000.00
Mar 31, 2023 -8,000.00
Dec 31, 2022 -16,000.00
Sep 30, 2022 201,000.00
Jun 30, 2022 122,000.00
Mar 31, 2022 -15,000.00
Dec 31, 2021 1.07 Mn
Sep 30, 2021 -265,000.00
Jun 30, 2021 -394,000.00